Pharmacology News

As part of its public health mission, FDA has been monitoring for adverse effects from opioids and opioid-like substances for years. Two recent examples of concern are loperamide and kratom.

Dec. 1 marks the 32nd annual World AIDS Day, which was started to support people living with HIV/AIDS and to commemorate those who have died from the disease.

Although the FDA-mandated exclusivity of colchicine ended and generics were introduced to the market, prices have remained high, according to research published in JAMA Internal Medicine.

We are seeing an enormous rise in COVID-19 cases, but as we continue to focus on controlling the pandemic, it is vital that we prevent outbreaks of other vaccine-preventable infectious diseases.

Since the start of the COVID-19 pandemic, clinicians have needed to take alternative approaches to provide care for patients with the novel coronavirus.

Results from the EMPOWUR extension study presented at the virtual International Continence Society Annual Meeting showed that vibegron, a beta-3 adrenergic agonist taken daily, could help treat patients with overactive bladder.

Researchers have developed a machine-learning algorithm that can predict opioid use disorder in patients prior to clinical diagnosis, according to a study published in Pharmacology Research & Perspectives.

Prescription opioid use appeared to increase risk for depression, according to results of a mendelian randomization analysis published in JAMA Psychiatry.

The Infectious Diseases Society of America recently published updated guidance in Clinical Infectious Diseases on providing evidence-based primary care to patients with HIV.

Statin therapy appeared to be more beneficial in patients with a life expectancy of more than 2.5 years, a meta-analysis showed. The data also indicated that statins did not provide a mortality benefit.